Utilization of the NMP 22 ® BladderChek ® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence
نویسندگان
چکیده
©2008 UroToday International Journal / Vol 1 / Iss 5 / November / doi:10.3834/uij.1939-4810.2008.11.03 http://www.urotodayinternationaljournal.com Ravi Munver*†, Ilya A. Volfson*, Debra L. Fromer*†, Richard A. Watson*†, Grant I. S. Disick*, Alexandra Sawczuk*, Ihor S. Sawczuk*† *Hackensack University Medical Center, Hackensack, NJ †Touro University College of Medicine, Hackensack, NJ Submitted on June 2, 2008 Accepted for Publication on October 16, 2008
منابع مشابه
Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
OBJECTIVE To assess the clinical performance of the NMP22 BladderChek test, which is a qualitative test, and to compare it with voided urine cytology for the detection of recurrent bladder cancer. We also evaluated whether cystoscopy can be omitted from the surveillance protocol by combining the two tests. METHODS A total of 131 patients with a history of superficial transitional cell carcino...
متن کاملThe Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with Atypical Urine Cytology
PURPOSE Difficulty exists in interpreting the significance of atypical urine cytology. This study was performed to assess the diagnostic utility of nuclear matrix protein-22 (NMP-22) testing when atypical cells are detected during urine cytology. MATERIALS AND METHODS Among patients whose urine cytology was reported as atypical between January 2004 and December 2009, a total of 275 who also u...
متن کاملComparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
AIM To compare the results of bladder tumor associated antigen (BTA TRAK), nuclear matrix protein 22 (NMP 22) and voided urine cytology (VUC) in detecting bladder cancer. METHODS A total of 135 elderly male and 50 healthy volunteers enrolled in this study were classified into three groups: (i) 93 patients with bladder cancer; (ii) 42 patients with urinary benign conditions; and (iii) 50 healt...
متن کاملPatients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation.
OBJECTIVES Urine based tumor markers have uncertain utility in diagnosis or surveillance of patients with bladder cancer while cytology is commonly used. We evaluated whether cytology provides additional diagnostic information in patients with a negative NMP22® BladderChek® test (BladderChek) and negative cystoscopy. MATERIALS AND METHODS We performed subset analyses of 2 large prospective mu...
متن کاملEvaluation of Sensitivity and Specificity of Urine Survivin As A New Molecular Marker in Diagnosis of Bladder Tumors
Bladder cancer is one of the most common forms of cancers in the world. The current gold standards for itsdiagnosis are cystoscopy and urine cytology. Cystoscopy, a naked eye assessment of the bladder, is invasive, uncomfortable and costly with a great deal of personal variability in its results; while urine cytology has high specificity but low sensitivity, particularly for low-grade les...
متن کامل